bioMerieux (EYWN) Stock Forecast & Price Target
EYWN Analyst Ratings
Hold
1Buy2Hold1Sell
Based on 4 analysts giving stock ratings to bioMerieux in the past 3 months
EYWN Stock 12 Month Forecast
Average Price Target
EUR 83.50▼(-6.91% Downside)Based on 4 Wall Street analysts offering 12 month price targets for bioMerieux in the last 3 months. The average price target is EUR 83.50 with a high forecast of EUR 103.00 and a low forecast of EUR 66.00. The average price target represents a -6.91% change from the last price of EUR 89.70.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 103.00
AverageEUR 83.50
LowEUR 66.00
Highest Price TargetHighestEUR 103.00Average Price TargetEUR 83.50Lowest Price TargetLowestEUR 66.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jan Koch | Deutsche Bank | EUR 75→EUR 103 | buy | 14.83%Upside | Upgraded | 10/28/26 | ||
| Natalia Webster | RBC Capital | EUR 85 | hold | -5.24%Downside | Reiterated | 10/23/26 | ||
| Aisyah Noor | Morgan Stanley | EUR 64→EUR 66 | sell | -26.42%Downside | Reiterated | 09/11/26 | ||
| Charles Pitman CFA | Barclays | EUR 75→EUR 80 | hold | -10.81%Downside | Reiterated | 09/07/26 | ||
| Kavya Deshpande | UBS | EUR 80→EUR 78 | hold | -13.04%Downside | Reiterated | 07/29/26 | ||
| David Westenberg | Piper Sandler | EUR 80 | hold | -10.81%Downside | Reiterated | 07/29/26 | ||
| Pablo de Renteria | Kepler Capital | EUR 85 | buy | -5.24%Downside | Reiterated | 06/25/26 | ||
| David Adlington | J.P. Morgan | EUR 120.50→EUR 71.60 | hold | -20.18%Downside | Reiterated | 04/24/26 | ||
| Hugo Solvet | Exane BNP Paribas | EUR 100 | hold | 11.48%Upside | Downgraded | 01/28/26 | ||
| Anna Ractliffe | Bank of America Securities | EUR 90→EUR 115 | hold | 28.21%Upside | Upgraded | 12/12/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jan Koch | 10/28/26 | EUR 75→EUR 103 | buy | 14.83%Upside | Upgraded | Deutsche Bank | ||
| Natalia Webster | 10/23/26 | EUR 85 | hold | -5.24%Downside | Reiterated | RBC Capital | ||
| Aisyah Noor | 09/11/26 | EUR 64→EUR 66 | sell | -26.42%Downside | Reiterated | Morgan Stanley | ||
| Charles Pitman CFA | 09/07/26 | EUR 75→EUR 80 | hold | -10.81%Downside | Reiterated | Barclays | ||
| Kavya Deshpande | 07/29/26 | EUR 80→EUR 78 | hold | -13.04%Downside | Reiterated | UBS | ||
| David Westenberg | 07/29/26 | EUR 80 | hold | -10.81%Downside | Reiterated | Piper Sandler | ||
| Pablo de Renteria | 06/25/26 | EUR 85 | buy | -5.24%Downside | Reiterated | Kepler Capital | ||
| David Adlington | 04/24/26 | EUR 120.50→EUR 71.60 | hold | -20.18%Downside | Reiterated | J.P. Morgan | ||
| Hugo Solvet | 01/28/26 | EUR 100 | hold | 11.48%Upside | Downgraded | Exane BNP Paribas | ||
| Anna Ractliffe | 12/12/25 | EUR 90→EUR 115 | hold | 28.21%Upside | Upgraded | Bank of America Securities |
Stocks with the Highest Top Analyst Consensus in the General Sector
Best Analysts Covering bioMerieux
3 Months
Success Rate2/5 ratings generated profit
40%
Average Return
-2.70%
Copying Jan Koch's trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -2.70% per trade.
1 Year
Success Rate2/5 ratings generated profit
40%
Average Return
-1.74%
Copying Jan Koch's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -1.74% per trade.
2 Years
Success Rate1/3 ratings generated profit
33%
Average Return
-19.33%
Copying Aisyah Noor's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -19.33% per trade.
EYWN Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 0 | 1 | 1 |
| Hold | 9 | 9 | 5 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 12 | 11 | 6 | 4 | 4 |
In the current month, EYWN has received 1 Buy Ratings, 2 Hold Ratings, and 1 Sell Ratings. EYWN average Analyst price target in the past 3 months is 83.50.
EYWN Financial Forecast
HighEUR 2.54
ConsensusEUR 2.45
LowEUR 2.29
EYWN Earnings Forecast
Next quarter’s earnings estimate for EYWN is EUR 2.45 with a range of EUR 2.29 to EUR 2.54. The previous quarter’s EPS was EUR 1.99. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
HighEUR 2.19B
ConsensusEUR 2.17B
LowEUR 2.15B
EYWN Sales Forecast
Next quarter’s sales forecast for EYWN is EUR 2.17B with a range of EUR 2.15B to EUR 2.19B. The previous quarter’s sales results were EUR 1.96B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
EYWN Stock Forecast FAQ
What is DE:EYWN’s average 12-month price target, according to analysts?
Based on analyst ratings, bioMerieux’s 12-month average price target is €83.50.
What is DE:EYWN’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:EYWN, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is bioMerieux a Buy, Sell or Hold?
bioMerieux has a consensus rating of Hold, which is based on 1 buy ratings, 2 hold ratings and 1 sell ratings.
What is bioMerieux’s share price target?
The average share price target for bioMerieux is €83.50. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €103.00, and the lowest forecast is €66.00. The average share price target represents a 6.91% decrease from the current price of €89.7.
What do analysts say about bioMerieux?
bioMerieux’s analyst rating consensus is a Hold. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of bioMerieux?
To buy shares of DE:EYWN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
